dc.contributor.author |
Somtaporn Ueathaweephol |
th_TH |
dc.contributor.author |
Panuwat Wongwattana |
th_TH |
dc.contributor.author |
Waruttaporn Chanlalit |
th_TH |
dc.contributor.author |
Therdkiat Trongwongsa |
th_TH |
dc.contributor.author |
Sirilak Sutthinont |
th_TH |
dc.date.accessioned |
2022-03-28T06:12:39Z |
|
dc.date.available |
2022-03-28T06:12:39Z |
|
dc.date.issued |
2022 |
|
dc.identifier.uri |
https://e-acfs.org/upload/pdf/acfs-2022-00612.pdf |
|
dc.identifier.uri |
https://ir.swu.ac.th/jspui/handle/123456789/19378 |
|
dc.description.abstract |
Primary lymphoma originating from the lacrimal drainage system is a rare disease. Such lymphomas are mostly B-cell in origin and present nonspecific symptoms. The treatment of malignant lymphoma of the lacrimal drainage system is slightly different. We present the case of a 71-year-old woman with a painless mass below the medial canthus. Computed tomography (CT) scan of the orbit revealed a mass invading the right lacrimal sac. An incision biopsy was obtained, and the pathologic findings suggested a diagnosis of primary diffuse large B cell lymphoma of the lacrimal sac. The patient was treated with chemotherapy and intrathecal methotrexate. After completing eight cycles of chemotherapy, the patient was followed up by a CT scan, which revealed nearly total resolution of an ill-defined enhancing mass. At the time of this case report writing, the patient is in complete remission at six months with no other complications. |
th_TH |
dc.language.iso |
en |
th_TH |
dc.subject |
Case reports |
th_TH |
dc.subject |
Diffuse large B-cell lymphoma |
th_TH |
dc.subject |
Nasolacrimal sac |
th_TH |
dc.subject |
Lacrimal sac |
th_TH |
dc.subject |
Lymphoma |
th_TH |
dc.title |
Lacrimal sac lymphoma: a case report |
th_TH |
dc.type |
Article |
th_TH |
dc.identifier.bibliograpycitation |
Arch Craniofac Surg Vol.23 No.1, 43-47 |
th_TH |
dc.identifier.doi |
https://doi.org/10.7181/acfs.2022.00612 |
|